Last update 31 Jan 2026

Colorectal cancer vaccine (Immunovo/Pepscan Therapeutics)

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
hVEGF26-104/RFASE
Target
VEGF-A
Action
inhibitors, stimulants
Mechanism
VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors), Immunostimulants
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmMetastatic Solid TumorNeoplasm Metastasis+ [1]
Originator Organization
Pepscan Systems BV
Active Organization-
Inactive Organization
Pepscan Holding NVPepscan Holding NVImmunovo BVImmunovo BVUniversitätsklinikum Hamburg-EppendorfUniversitätsklinikum Hamburg-Eppendorf
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Colorectal cancer vaccine (Immunovo/Pepscan Therapeutics)
NCT02237638
/ CompletedPhase 1IIT
A Phase I Open-label Clinical Trial, Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients With Advanced Solid Tumors
100 Clinical Results associated with Colorectal cancer vaccine (Immunovo/Pepscan Therapeutics)
Login to view more data
100 Translational Medicine associated with Colorectal cancer vaccine (Immunovo/Pepscan Therapeutics)
Login to view more data
100 Patents (Medical) associated with Colorectal cancer vaccine (Immunovo/Pepscan Therapeutics)
Login to view more data
100 Deals associated with Colorectal cancer vaccine (Immunovo/Pepscan Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Solid tumorPhase 1
Netherlands
Universitätsklinikum Hamburg-EppendorfUniversitätsklinikum Hamburg-Eppendorf
29 Apr 2021
Advanced Malignant Solid NeoplasmPhase 1
Netherlands
Immunovo BVImmunovo BV
01 Apr 2014
Metastatic Solid TumorPhase 1
Netherlands
Immunovo BVImmunovo BV
01 Apr 2014
Neoplasm MetastasisPhase 1
Netherlands
Immunovo BVImmunovo BV
01 Apr 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free